Advertisement
Advertisement
Trending on Dermatology Times
1
Evommune's EVO756 Misses Primary End Point in Phase 2b CSU Trial, Development Continues in AD and Migraine
2
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis Down to Age 2
3
Top 5 Articles of the Month: June 2026
4
Understanding Vitiligo: From Cosmetic Misconception to Autoimmune Reality
5